Cytokine-induced increases in ADAMTS-4 messenger RNA expression do not lead to increased aggrecanase activity in ADAMTS-5-deficient mice.
about
E74-like factor 3 (ELF3) impacts on matrix metalloproteinase 13 (MMP13) transcriptional control in articular chondrocytes under proinflammatory stress.Human Cytomegalovirus Immediate-Early 1 Protein Rewires Upstream STAT3 to Downstream STAT1 Signaling Switching an IL6-Type to an IFNγ-Like ResponseChondrogenesis, chondrocyte differentiation, and articular cartilage metabolism in health and osteoarthritis.Evidence for lysosomal exocytosis and release of aggrecan-degrading hydrolases from hypertrophic chondrocytes, in vitro and in vivo.Silencing of miR-101 Prevents Cartilage Degradation by Regulating Extracellular Matrix-related Genes in a Rat Model of Osteoarthritis.Inflammation in osteoarthritis.Homeostatic mechanisms in articular cartilage and role of inflammation in osteoarthritis.Inhibition of aggrecanases as a therapeutic strategy in osteoarthritis.Bioactivity in an Aggrecan 32-mer Fragment Is Mediated via Toll-like Receptor 2.New developments in the treatment of osteoarthritis - focus on biologic agents.Inhibition of TAK1 and/or JAK can rescue impaired chondrogenic differentiation of human mesenchymal stem cells in osteoarthritis-like conditionsInterleukin-6 is elevated in synovial fluid of patients with focal cartilage defects and stimulates cartilage matrix production in an in vitro regeneration modelMurine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone MassSKI306X inhibition of glycosaminoglycan degradation in human cartilage involves down-regulation of cytokine-induced catabolic genes.Investigating ADAMTS-mediated aggrecanolysis in mouse cartilage.
P2860
Q35728539-2BC0746C-A737-4C8D-AD63-A79556497E68Q36069672-E16DD8F1-B0D0-4819-9794-D19E7DDBAA35Q36111296-39897A44-2DD2-43D4-8973-997D770E6F57Q36432069-00416AF5-B6A0-473A-9714-F7157AAF1F9CQ36757016-2A39BF50-9A5F-4F58-9DDF-1FF064BA0685Q37608903-16F9F615-79FC-4A44-A1AC-7256FE6D68CAQ37706611-76281F27-C51D-4448-8196-DD924F3942A5Q38261368-FF58FF9B-A0CF-463E-B983-D3EF91C84610Q38906815-15449529-602B-40B6-A8FD-3D0B7B885B2AQ38982848-BD1C4C27-0CD7-4718-AFC4-71A7EC9C898CQ41762692-8143F380-2918-4317-A2A5-04F46291E81DQ41901416-660FC73F-86B2-4AF5-B64D-FC370D34A085Q42380690-61B9AE65-868F-47A6-AA0C-775C75869083Q42878322-B1CCCDA1-635F-4C51-9A2C-875E957155C9Q50280462-F4834F25-0634-46FC-B8C6-EA214E905876
P2860
Cytokine-induced increases in ADAMTS-4 messenger RNA expression do not lead to increased aggrecanase activity in ADAMTS-5-deficient mice.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Cytokine-induced increases in ...... ty in ADAMTS-5-deficient mice.
@en
Cytokine-induced increases in ...... ty in ADAMTS-5-deficient mice.
@nl
type
label
Cytokine-induced increases in ...... ty in ADAMTS-5-deficient mice.
@en
Cytokine-induced increases in ...... ty in ADAMTS-5-deficient mice.
@nl
prefLabel
Cytokine-induced increases in ...... ty in ADAMTS-5-deficient mice.
@en
Cytokine-induced increases in ...... ty in ADAMTS-5-deficient mice.
@nl
P2093
P2860
P356
P1476
Cytokine-induced increases in ...... ity in ADAMTS-5-deficient mice
@en
P2093
Fraser M Rogerson
Michael E Deutscher
Yuen M Chung
P2860
P304
P356
10.1002/ART.27661
P577
2010-11-01T00:00:00Z